壹傳媒(00282.HK)將軍澳工業村用地違契 黎智英被裁定兩項欺詐罪成
壹傳媒(00282.HK)創辦人黎智英及時任行政總監黃偉強被控欺詐科技園、違反租契案,今日(25日)在區域法院裁決,法官裁定黎智英黃偉強兩人欺詐罪成。
法官裁決時指出,在科技園特殊租約框架下,令承租人享有低地租及長租期優惠,承租人因此要承擔更嚴格的租約規定。
控罪指,黎智英及黃偉強於2016年1月至2020年5月連同時任壹傳媒營運總裁周達權及其他人隱瞞科技園公司,有關將軍澳工業村蘋果大樓並非按租契用途使用。黎智英亦被控另一項欺詐罪,指他沒有按1995年所訂租契協議使用工業村相關用地,意圖詐騙科技園公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.